Cervical carcinoma affects around 3400 women in the UK each year and advanc
ed disease is routinely treated with radiation. As part of a programme to e
stablish rapid and convenient methods of predicting tumour and patient resp
onses to radiotherapy, we have examined the relationship between the pre-tr
eatment expression of the Ku components of the DNA damage recognition compl
ex DNA-PK and patient survival in cervical carcinoma. Using immunohistochem
istry of formalin-fixed sections of tumour biopsies, antibodies to Ku70 and
Ku80 stained identical regions of tumour and there was a high degree of co
rrelation between the mean number of cells stained positive far the two com
ponents in 77 tumours (r = 0.82, P < 0.001). In 53 tumours there was a bord
erline significant correlation between measurements of tumour radiosensitiv
ity (surviving fraction at 2 gray: SF2) and Ku70 expression (r = 0.26, P =
0.057) and no correlation for Ku80 (r = 0.18, P = 0.19). However, all tumou
rs with a low number of Ku70 or Ku80 positive cells were radiosensitive. Fu
rthermore, using log-rank analysis there was significantly higher survival
in the patients whose tumours had a low Ku70 expression (P = 0.046). This d
ifference was also reflected with Ku80, but did not reach statistical signi
ficance (P = 0.087). The study suggests that lack of Ku protein leads to ra
diosensitivity in some tumours and that other factors are responsible for r
adiosensitive tumours with high Ku expression. It is likely that the most a
ccurate prediction of treatment outcome will lie in assessing the expressio
n of several proteins involved in the recognition and repair of DNA damage,
one of which will be Ku. (C) 2000 Cancer Research Campaign.